• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Microbiol . Protection of Ducks Against Highly Pathogenic H5Nx Avian Influenza Viruses by HA Cleavage Site Peptide Vaccine

tetano

Editor, Senior Moderator
Curr Microbiol


. 2025 Mar 26;82(5):211.
doi: 10.1007/s00284-025-04182-5. Protection of Ducks Against Highly Pathogenic H5Nx Avian Influenza Viruses by HA Cleavage Site Peptide Vaccine

Heejeong Seo[SUP] 1 2 [/SUP], Yunyueng Jang[SUP] 1 [/SUP], Sang Heui Seo[SUP] 3 4 [/SUP]



Affiliations
Abstract

Highly pathogenic H5Nx avian influenza viruses are endemic in animals in many countries. These viruses cause the severe diseases in chickens, but they cause much milder diseases in ducks. The vaccination is one of the tools to prevent the infections of ducks by highly pathogenic H5Nx avian influenza viruses. Here, we studied the efficacy of oil-adjuvanted H5 cleavage peptide vaccine in ducks. The vaccinated ducks challenged with H5N6 and H5N8 avian influenza viruses were protected without viral detection in the tracheal and cloacal swabs. The protective immunity in the immunized ducks lasted until 16 weeks post-vaccination. Our results suggest that H5 cleavage site peptide vaccine can be one of the candidate vaccines to provide the protective immunity to ducks against H5Nx avian influenza viruses.Please confirm if the author names are presented accurately and in the correct sequence. Also, kindly confirm the details in the metadata are correct.Yes, It's correct.Please check and confirm that the authors and their respective affiliations have been correctly identified and amend if necessary.Yes, It's correct.Please confirm the section headings are correctly identified.Yes, It's correct.Kindly check and confirm the edit made in the title.Yes, It's OK. LE: Kindly check and confirm whether the edit made in the article title is appropriate.Yes, It's OK.


 
Back
Top Bottom